- No posts yet.
- WHO approves first Bundibugyo diagnostic test and begins clinical trial for treatments as outbreak surpasses 1,400 cases in DRC. 7-day briefing • 2026-07-03 - 2026-07-09
- Bundibugyo outbreak shifts from emergency response to operational countermeasures as vaccine gap fades from narrative. 90-day briefing • 2026-04-11 - 2026-07-09
- Bundibugyo outbreak response shifts from guidelines to diagnostics and clinical trials, yet vaccine gap remains unresolved. 30-day briefing • 2026-06-10 - 2026-07-09
- WHO approves first Bundibugyo diagnostic test and launches treatment trial amid escalating outbreak 7-day briefing • 2026-07-01 - 2026-07-07
- WHO releases updated filovirus clinical guidelines as Uganda battles Bundibugyo Ebola outbreak without licensed vaccine. 7-day briefing • 2026-06-24 - 2026-06-30
- Bundibugyo Ebola outbreak in Uganda highlights vaccine gap as WHO issues first filovirus clinical guidelines 7-day briefing • 2026-06-17 - 2026-06-23
- Bundibugyo Ebola strain lacks vaccine, posing containment challenges in Uganda 7-day briefing • 2026-06-10 - 2026-06-16
- Bundibugyo Ebola outbreak in DRC and Uganda spreads rapidly; no approved countermeasures, WHO prioritizes experimental therapies. 7-day briefing • 2026-05-29 - 2026-06-04
- ERVEBO Vaccine: FDA Approval Page fda.gov | 62d ago
- FDA approves Ebanga (ansuvimab-zykl) for Zaire ebolavirus treatment fda.gov | 62d ago
- Bundibugyo Ebola outbreak escalates to PHEIC with 139 dead, 600 suspected cases across DRC and Uganda. 30-day briefing • 2026-04-22 - 2026-05-21
- WHO declares PHEIC for Bundibugyo Ebola outbreak in DRC and Uganda as cases exceed 600 suspected, 139 dead. 7-day briefing • 2026-05-15 - 2026-05-21
- FDA approves Ebanga for Zaire ebolavirus treatment fda.gov | 2044d ago
Showing page 1 of 1
(18 total results)
← Prev
Next →